Editorial policy
Editorial policy
Gene Atlas publishes evidence-based health and science content. This page explains how we research, cite, and review what we publish — and where our limits are.
How we research
We build on established, public research — the GWAS Catalog, Open Targets, and PubMed — and weight the evidence by study sample size, genome-wide significance (p<5×10⁻⁸), and independent replication. This is open, peer-reviewed science — not a proprietary black box. Where the evidence is weak or conflicting, we say so rather than overstate it.
Citation standard
Every health claim we publish is cited. Each article ends with a numbered reference list linking to the primary literature (with DOI or PubMed identifiers where available), so any statement can be traced back to its source. Traits in our reports additionally carry a transparency rating that reflects how strong the underlying evidence is.
Review before publication
Health content is reviewed before it is published by the Gene Atlas Science & Longevity Team. When an article has a named medical or scientific reviewer, that reviewer is credited in the byline; until an individual is assigned, articles carry the team byline. We correct errors when we find them and update articles as the science changes — the last updated date on each article reflects its most recent substantive revision.
How we describe genetic risk
Gene Atlas reports are polygenic risk scores (PRS) across roughly 3,000 markers, expressed relative to the general population — never absolute probabilities, and never a claim that genetics determines or guarantees an outcome. We frame genetics as a tendency to discuss with a clinician, not a verdict.